PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

2 studies provide insight into stroke risk and prevention in young sickle cell anemia patients

St. Jude Children's Research Hospital investigators discuss results of research into managing iron overload associated with stroke prevention in young sickle cell patients and the search for genetic predictors of stroke risk

2010-12-07
(Press-News.org) Monthly blood transfusions combined with daily medication to remove the resulting excess iron remains the best approach for reducing the risk of recurrent strokes in young patients with sickle cell anemia, according to a preliminary analysis of a multicenter trial that includes St. Jude Children's Research Hospital.

The study compared the efficacy of two treatments for the potentially life-threatening problem of iron overload caused by chronic transfusion therapy. The transfusions are used to guard against additional strokes in young sickle cell anemia patients. The trial, known as SWiTCH or Stroke with Transfusion Changing to Hydroxyurea, was halted in May after an interim safety review determined the alternative therapy was not significantly better than the standard treatment at reducing iron buildup and was associated with an increased stroke risk.

Russell Ware, M.D., Ph.D., chair of the St. Jude Children's Research Hospital Department of Hematology and principal investigator of SWiTCH, discussed the results at the 52nd Annual Meeting of the American Society of Hematology. The meeting is being held December 4 -7 in Orlando, Fla.

Jonathan Flanagan, Ph.D., a staff scientist at St. Jude, presented results of another study that provide the first independent validation of an association between five common genetic variations and stroke risk in young sickle cell patients.

Between 70,000 and 100,000 individuals in the U.S. have sickle cell anemia. They make an abnormal hemoglobin molecule that sometimes takes on a twisted or sickle shape, disrupting blood flow and oxygen delivery throughout the body. Patients are vulnerable to a variety of problems, including organ damage, episodes of acute pain and stroke. Five to 10 percent of patients will suffer strokes before their 20th birthday. Up to 90 percent of patients will experience a recurrence.

Flanagan and his colleagues tried to validate earlier reports linking 38 genetic polymorphisms to stroke risk in sickle cell disease. Researchers compared the genetic makeup of 130 young sickle cell anemia (SCA) patients enrolled in the SWiTCH trial with 103 SCA patients enrolled in another study. The SWiTCH participants had suffered documented strokes while patients in the other trial had not.

Investigators validated the association between stroke risk and five single nucleotide polymorphisms (SNPs) in four genes. SNPs are small inherited variations in the makeup of particular genes and are sometimes used as markers of disease risk. "These findings reinforce earlier observations suggesting there is a genetic component to stroke risk in sickle cell anemia. We are now focusing on how these five SNPs might play a role in stroke development," said Flanagan, the poster's first author. Ware is the senior author.

Investigators also confirmed that the alpha-thalassemia trait is associated with a reduced stroke risk. Affected individuals carry two or three, rather than the usual four, genes for making one of the hemoglobin proteins needed to ferry oxygen throughout the body. Researchers reported no association between another inherited condition, G6PD deficiency, and strokes.

SWiTCH was a Phase III trial funded by the National Heart, Lung, and Blood Institute. Between October 2006 and April 2009, 133 children and adolescents ages 5 through 18 enrolled at one of 25 participating U.S. centers. All had a diagnosis of sickle cell anemia, had an average age of almost 13, had suffered at least one stroke and had undergone monthly blood transfusions for an average of seven years.

Sixty-six were randomly assigned to continue monthly transfusions and to take the drug deferasirox, or Exjade, daily to remove excess iron from their bodies. The remaining 67 patients were assigned to treatment with hydroxyurea daily for 30 months to reduce stroke risk and to undergo monthly blood removal to reduce iron buildup.

Monthly blood transfusions are 90 percent effective at preventing future strokes in sickle cell patients. But Ware said the resulting iron overload and other factors have fueled interest in alternative approaches to stroke prevention.

Hydroxyurea received U.S. Food and Drug Administration approval in 1998 for use in adults with SCA. The medication works by stimulating production of fetal hemoglobin, an alternative form of the molecule. A pilot study found the drug offered a possible alternative for managing stroke risk.

The SWiTCH study was halted after a review of data from 62 patients found no statistically significant difference in iron concentrations in the liver biopsies of the two treatment groups.

As expected, strokes were more common among patients receiving hydroxyurea than those who continued transfusion therapy. Seven of the 67 patients in the hydroxyurea group had another stroke. There were no additional strokes in the chronic transfusion patients.

INFORMATION:

St. Jude Children's Research Hospital

St. Jude Children's Research Hospital is internationally recognized for its pioneering research and treatment of children with cancer and other catastrophic diseases. Ranked the No. 1 pediatric cancer hospital by Parents magazine and the No. 1 children's cancer hospital by U.S. News & World Report, St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. St. Jude has treated children from all 50 states and from around the world, serving as a trusted resource for physicians and researchers. St. Jude has developed research protocols that helped push overall survival rates for childhood cancer from less than 20 percent when the hospital opened to almost 80 percent today. St. Jude is the national coordinating center for the Pediatric Brain Tumor Consortium and the Childhood Cancer Survivor Study. In addition to pediatric cancer research, St. Jude is also a leader in sickle cell disease research and is a globally prominent research center for influenza.

Founded in 1962 by the late entertainer Danny Thomas, St. Jude freely shares its discoveries with scientific and medical communities around the world, publishing more research articles than any other pediatric cancer research center in the United States. St. Jude treats more than 5,700 patients each year and is the only pediatric cancer research center where families never pay for treatment not covered by insurance. St. Jude is financially supported by thousands of individual donors, organizations and corporations without which the hospital's work would not be possible. In 2010, St. Jude was ranked the most trusted charity in the nation in a public survey conducted by Harris Interactive, a highly respected international polling and research firm. For more information, go to www.stjude.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

New tool in the early detection of bowel disease

2010-12-07
An international team of researchers led by the University of East Anglia (UEA) have developed a new kind of endoscope to aid the early detection and diagnosis of inflammatory bowel disease. The Confocal Laser Endomicroscope (CLE) contains a powerful microscope which allows clinicians to view the bacteria that are thought to trigger diseases of the bowel such as Crohn's disease and ulcerative colitis. "Bacteria within the wall of the gut are already believed to play an important role in the development of inflammatory bowel disease and we now have a powerful new tool ...

Researchers discover a way to delay Christmas tree needle loss

2010-12-07
Quebec City, December 6, 2010—Researchers at Université Laval, in collaboration with Nova Scotia Agricultural College, have discovered what causes Christmas tree needles to drop off, and how to double the lifespan of Christmas trees in homes. The authors presented their findings in a recent issue of the scientific journal Trees. The researchers have identified a plant hormone—ethylene—responsible for needle loss in balsam fir. They made the discovery by placing fir branches in containers of water inside a growth chamber. After ten days the branches began to produce ethylene ...

Brand recognition can help hotels survive economic downturns

Brand recognition can help hotels survive economic downturns
2010-12-07
Brand named hotels fare better than independently operated properties in economic downturns, according to a team of international researchers. A study of the performance of hotels during both economic recessions and expansions indicates that brand named hotels are more profitable than independent hotels under all economic conditions, but the difference is particularly significant during recessions, said John O'Neill, associate professor of hospitality management, Penn State. "There has been a lot of debate in the hotel industry about the advantages of brand affiliation ...

Study reveals how taking an active role in learning enhances memory

Study reveals how taking an active role in learning enhances memory
2010-12-07
CHAMPAIGN, Ill. — Good news for control freaks! New research confirms that having some authority over how one takes in new information significantly enhances one's ability to remember it. The study, in the journal Nature Neuroscience, also offers a first look at the network of brain structures that contribute to this phenomenon. "Having active control over a learning situation is very powerful and we're beginning to understand why," said University of Illinois psychology and Beckman Institute professor Neal Cohen, who led the study with postdoctoral researcher Joel Voss. ...

AgriLife researchers find way to cut food-irradiation levels by half

2010-12-07
COLLEGE STATION — A team of Texas AgriLife Research engineers has developed a way to cut by as much as half the amount of irradiation needed to kill 99.999 percent of salmonella, E. coli and other pathogens on fresh produce. By packing produce in a Mylar bag filled with pure oxygen, Dr. Carmen Gomes, AgriLife Research food safety engineer, and her colleagues found they could significantly reduce the amount of radiation needed to kill those pathogens. Reducing the amount of radiation is not so much a safety measure as it is a way to preserve quality of the produce, she ...

Report finds K-12 computer science education declining

2010-12-07
PITTSBURGH—Computer-related technology is increasingly driving the U.S. economy, yet computer science education is scant in most American elementary and secondary school classrooms and the number of introductory and Advanced Placement courses in computer science has actually declined in the last five years, according to a report released this fall. "Some states and some schools are offering some really excellent courses," said Mark Stehlik, co-author of the report, "Running on Empty: The Failure to Teach K-12 Computer Science in the Digital Age," http://www.acm.org/runningonempty/. ...

Fledgling ecosystem at Chicken Creek lets scientists observe how soil, flora and fauna develop

Fledgling ecosystem at Chicken Creek lets scientists observe how soil, flora and fauna develop
2010-12-07
How do ecosystems develop? No one really knows, yet. There is however one project, unique in the world, seeking to answer this question. In a former open-pit coal mining area in Brandenburg, Germany, a surface of six hectares was partitioned off and then left to its own resources. Scientists from the Technische Universitaet Muenchen (TUM), in collaboration with researchers from other institutions, are studying the development of soil, flora, and fauna there. With this research they aim to establish the factors that have a particularly strong influence on developing ecosystems. Young ...

Drug prevents post-traumatic stress syndrome

2010-12-07
CHICAGO --- Post-traumatic stress syndrome – when a severely stressful event triggers exaggerated and chronic fear – affects nearly 8 million people in the United States and is hard to treat. In a preclinical study, Northwestern Medicine scientists have for the first time identified the molecular cause of the debilitating condition and prevented it from occurring by injecting calming drugs into the brain within five hours of a traumatic event. Northwestern researchers discovered the brain becomes overly stimulated after a traumatic event causes an ongoing, frenzied ...

Pure nanotube-type growth edges toward the possible

2010-12-07
New research at Rice University could ultimately show scientists the way to make batches of nanotubes of a single type. A paper in the online journal Physical Review Letters unveils an elegant formula by Rice University physicist Boris Yakobson and his colleagues that defines the energy of a piece of graphene cut at any angle. Yakobson, a professor in mechanical engineering and materials science and of chemistry, said this alone is significant because the way graphene handles energy depends upon the angle -- or chirality -- of its edge, and solving that process for ...

Early safety results promising for Phase I/II trial of gene therapy treatment of hemophilia B

2010-12-07
Investigators report no evidence of toxicity in the four hemophilia B patients enrolled to date in a gene therapy trial using a vector under development at St. Jude Children's Research Hospital and UCL (University College London) to correct the inherited bleeding disorder. This trial was designed primarily as a safety test, with low and intermediate doses of the vector expected to produce little detectable Factor IX. The Factor IX protein helps the blood form clots. Individual with hemophilia B lack adequate levels of this clotting factor. The first participant in the ...

LAST 30 PRESS RELEASES:

Mysterious ‘Dark Dwarfs’ may be hiding at the heart of the Milky Way

Real-world data shows teclistamab can benefit many multiple myeloma patients who would have been ineligible for pivotal trial

Scientists reveal how a key inflammatory molecule triggers esophageal muscle contraction

Duration of heat waves accelerating faster than global warming

New mathematical insights into Lagrangian turbulence

Clinical trials reveal promising alternatives to high-toxicity tuberculosis drug

Artificial solar eclipses in space could shed light on Sun

Probing the cosmic Dark Ages from the far side of the Moon

UK hopes to bolster space weather forecasts with Europe's first solar storm monitor

Can one video change a teen's mindset? New study says yes - but there’s a catch

How lakes connect to groundwater critical for resilience to climate change, research finds

Youngest basaltic lunar meteorite fills nearly one billion-year gap in Moon’s volcanic history

Cal Poly Chemistry professor among three U.S. faculty to be honored for contributions to chemistry instruction

Stoichiometric crystal shows promise in quantum memory

Study sheds light on why some prostate tumors are resistant to treatment

Tree pollen reveals 150,000 years of monsoon history—and a warning for Australia’s northern rainfall

Best skin care ingredients revealed in thorough, national review

MicroRNA is awarded an Impact Factor Ranking for 2024

From COVID to cancer, new at-home test spots disease with startling accuracy

Now accepting submissions: Special Collection on Cognitive Aging

Young adult literature is not as young as it used to be

Can ChatGPT actually “see” red? New results of Google-funded study are nuanced

Turning quantum bottlenecks into breakthroughs

Cancer-fighting herpes virus shown to be an effective treatment for some advanced melanoma

Eliminating invasive rats may restore the flow of nutrients across food chain networks in Seychelles

World’s first: Lithuanian scientists’ discovery may transform OLED technology and explosives detection

Rice researchers develop superstrong, eco-friendly materials from bacteria

Itani studying translation potential of secure & efficient software updates in industrial internet of things architectures

Elucidating the source process of the 2021 south sandwich islands tsunami earthquake

Zhu studying use of big data in verification of route choice models

[Press-News.org] 2 studies provide insight into stroke risk and prevention in young sickle cell anemia patients
St. Jude Children's Research Hospital investigators discuss results of research into managing iron overload associated with stroke prevention in young sickle cell patients and the search for genetic predictors of stroke risk